17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.
Collin LJ, Woolpert KM, Kjaersgaard A, Ahern TP, Goodman M, McCullough LE, Waller LA, Christensen KB, Damkier P, Hamilton-Dutoit SJ, Lauridsen KL, Christiansen PM, Ejlertsen B, Sørensen HT, Cronin-Fenton DP, Lash TL
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.
Breast Cancer Res
Breast Cancer Res. 2025. PMID: 41469704.
Geospatial Analysis of Rural-Urban Access of Otolaryngology-Head and Neck Surgeons and Clinics in Vermont.
Kruglik CP, Yalovitser J, Rustad JL, Santagostino SF, Ostby ET, Herrington HC, Sajisevi MB
Geospatial Analysis of Rural-Urban Access of Otolaryngology-Head and Neck Surgeons and Clinics in Vermont.
Laryngoscope Investig Otolaryngol
Laryngoscope Investig Otolaryngol. 2025;11(1). PMID: 41479949; PMCID: PMC12754085.
Smoking reduction trajectories and their association with smoking cessation: a secondary analysis of longitudinal clinical trial data.
Barrows A, Klemperer E, Garavan H, Allgaier N, Lindson N, Taylor G
Smoking reduction trajectories and their association with smoking cessation: a secondary analysis of longitudinal clinical trial data.
BMJ Public Health
BMJ Public Health. 2025;3(2). PMID: 41458239; PMCID: PMC12742168.
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study.
Bhave M, Jhaveri KL, Kaufman PA, Aftimos P, Lombard J, Giridhar KV, Im SA, Ma CX, Lee KT, Kim SB, Sohn J, Li Y, Yuen E, Estrem ST, Nguyen B, Makena MR, Ismail-Khan R, Beeram M
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study.
Breast Cancer Res
Breast Cancer Res. 2025. PMID: 41423595.
Effect of race and ethnicity on advanced breast cancer risk prediction model performance.
Kerlikowske K, Chen S, Sprague BL, Tice JA, Miglioretti DL, Hubbard RA
Effect of race and ethnicity on advanced breast cancer risk prediction model performance.
NPJ Digit Med
NPJ Digit Med. 2025;8(1). PMID: 41392273; PMCID: PMC12717068.
An Examination of Strategies to Improve Access to Medical Nutrition Therapy among Cancer Patients in the United States: A Narrative Review and a Call to Action.
Gloss B, Bhurosy T
An Examination of Strategies to Improve Access to Medical Nutrition Therapy among Cancer Patients in the United States: A Narrative Review and a Call to Action.
Curr Nutr Rep
Curr Nutr Rep. 2025;14(1). PMID: 41351737.
Evaluating safety of observation after resection of low- and intermediate-grade major salivary cancers with isolated perineural invasion with or without facial nerve sacrifice.
Bourdillon AT, Callas P, Sajisevi M, Plonowska-Hirschfeld KA, Holcomb A, Ryan WR
Evaluating safety of observation after resection of low- and intermediate-grade major salivary cancers with isolated perineural invasion with or without facial nerve sacrifice.
Am J Otolaryngol
Am J Otolaryngol. 2025;47(1). PMID: 41343952.
Feasibility and Acceptability of an 8-Week Supportive Care Intervention for Cancer Caregivers Adapted for Rural Settings.
Kent EE, Deal AM, Sperry SS, Nakamura ZM, Gellin M, Kovacs J, Martin C, Reblin M
Feasibility and Acceptability of an 8-Week Supportive Care Intervention for Cancer Caregivers Adapted for Rural Settings.
Psychooncology
Psychooncology. 2025;34(12). PMID: 41310279.
Primary Well-Differentiated Neuroendocrine Tumor of the Common Hepatic Duct.
Wootton A, Kennedy JM, O'Neill CH
Primary Well-Differentiated Neuroendocrine Tumor of the Common Hepatic Duct.
Int J Surg Pathol
Int J Surg Pathol. 2025. PMID: 41324989.
Rural-Urban Differences in the Prevalence of Chronic Pain Among Adult Cancer Survivors.
Choi H, Hallgren E, Reblin M, Tracy JK, Ziller E
Rural-Urban Differences in the Prevalence of Chronic Pain Among Adult Cancer Survivors.
JAMA Netw Open
JAMA Netw Open. 2025;8(12). PMID: 41405889; PMCID: PMC12712726.
Age, cumulative psychosocial risk factors, and health disparities in U.S. adult cigarette smoking: 2002-2019.
Chen FF, Chen FF, Klemperer EM, Klemperer EM, Erath TG, Erath TG, DeSarno M, DeSarno M, Leventhal AM, Leventhal AM, Higgins ST, Higgins ST
Age, cumulative psychosocial risk factors, and health disparities in U.S. adult cigarette smoking: 2002-2019.
BMC Med
BMC Med. 2025;23(1). PMID: 41310668; PMCID: PMC12661708.
A comparison of pixel intensity-based and object-based image analysis software algorithms for assessing immunohistochemical staining of sections from paraffin-embedded human tumor samples.
Kimambo SE, Kimambo SE, Overton J, Overton J, Bouffard NA, Bouffard NA, Lee K, Lee K, Ambaye A, Ambaye A, Taatjes DJ, Taatjes DJ
A comparison of pixel intensity-based and object-based image analysis software algorithms for assessing immunohistochemical staining of sections from paraffin-embedded human tumor samples.
Histochem Cell Biol
Histochem Cell Biol. 2025;163(1). PMID: 41288752.
Coordinated transfer of DNA between Pol θ and Pol δ resets microhomology choice during double-strand break repair.
Li Y, Li Y, Returan M, Returan M, Guerin AT, Guerin AT, Averill AM, Averill AM, Oladapo D, Oladapo D, Doublié S, Doublié S, Wood RD, Wood RD
Coordinated transfer of DNA between Pol θ and Pol δ resets microhomology choice during double-strand break repair.
Proc Natl Acad Sci U S A
Proc Natl Acad Sci U S A. 2025;122(47). PMID: 41259142; PMCID: PMC12663940.
Differences in rural and urban patient perceptions of facilitative factors for cancer clinical trial participation.
Lent MC, Lent MC, Cerutti J, Cerutti J, Reblin M, Reblin M, Holcombe RF, Holcombe RF
Differences in rural and urban patient perceptions of facilitative factors for cancer clinical trial participation.
BMC Health Serv Res
BMC Health Serv Res. 2025;25(1). PMID: 41257757; PMCID: PMC12628826.
Stable False-Negative Rates for Mammography in the Breast Cancer Surveillance Consortium Over Time.
Kerlikowske K, Kerlikowske K, Sprague BL, Sprague BL, Miglioretti DL, Miglioretti DL
Stable False-Negative Rates for Mammography in the Breast Cancer Surveillance Consortium Over Time.
AJR Am J Roentgenol
AJR Am J Roentgenol. 2025. PMID: 41258656.
Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline.
Anker CJ, Anker CJ, Arshad J, Arshad J, Cellini F, Cellini F, Dehal A, Dehal A, Dolan J, Dolan J, Gillett SR, Gillett SR, Haddock MG, Haddock MG, Haustermans K, Haustermans K, Hong TS, Hong TS, Howell KJ, Howell KJ, Jabbour SK, Jabbour SK, Kitano M, Kitano M, Lin C, Lin C, Lloyd S, Lloyd S, Peterson J, Peterson J, Roeder F, Roeder F, Smith GL, Smith GL, Stewart J, Stewart J, Tchelebi LT, Tchelebi LT, Bradfield L, Bradfield L, Willett CG, Willett CG
Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline.
Pract Radiat Oncol
Pract Radiat Oncol. 2025. PMID: 41317985.
Hospital Admission and Survival of Patients With Brain Metastases Diagnosed in the Emergency Care Setting.
Soto DJ, Soto DJ, Lundberg CW, Lundberg CW, D'Agostino E, D'Agostino E, Wirth S, Wirth S, Wendel S, Wendel S, Amidon RF, Amidon RF, Catalino MP, Catalino MP, Lobo JM, Lobo JM, Anderson RT, Anderson RT, Brady W, Brady W, Nguyen L, Nguyen L, Schneider B, Schneider B, Guterman I, Guterman I, Sheehan JP, Sheehan JP, Bovi JA, Bovi JA, Thomas AA, Thomas AA, Fadul CE, Fadul CE
Hospital Admission and Survival of Patients With Brain Metastases Diagnosed in the Emergency Care Setting.
JCO Oncol Pract
JCO Oncol Pract. 2025. PMID: 41237362.
Greenness and its interaction with air pollution in relation to postmenopausal breast cancer risk in UK Biobank.
Smotherman C, Smotherman C, Sprague BL, Sprague BL, Braithwaite D, Braithwaite D, Yaghjyan L, Yaghjyan L
Greenness and its interaction with air pollution in relation to postmenopausal breast cancer risk in UK Biobank.
PLoS One
PLoS One. 2025;20(11). PMID: 41223176; PMCID: PMC12611134.
Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology.
Gillis NE, Schmidt SI, Lange CA
Split Decisions in Hormone Signaling: Distinct Roles for Progesterone Receptor Isoforms in Breast Cancer Biology.
Endocrinology
Endocrinology. 2025;166(12):8300210. PMID: 41128647; PMCID: PMC12602873.
Thyroid Hormone Receptor β Suppresses Cancer Cell Activity by Differential Regulation of Glycogen Metabolism.
Zielinski JM, Zielinski JM, Tomczak JA, Tomczak JA, Amiel E, Amiel E, Carr FE, Carr FE
Thyroid Hormone Receptor β Suppresses Cancer Cell Activity by Differential Regulation of Glycogen Metabolism.
Endocrinology
Endocrinology. 2025;166(12). PMID: 41129693; PMCID: PMC12603364.
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M, Smith M, Piulats J, Piulats J, Todenhöfer T, Todenhöfer T, Lee JL, Lee JL, Arija JA, Arija JA, Mazilu L, Mazilu L, Azad A, Azad A, Alonso-Gordoa T, Alonso-Gordoa T, McGovern U, McGovern U, Choudhury A, Choudhury A, Horvath L, Horvath L, Ye D, Ye D, Han W, Han W, Suzuki H, Suzuki H, Uemura H, Uemura H, McKay R, McKay R, Ades S, Ades S, Fléchon A, Fléchon A, Pieczonka C, Pieczonka C, Fernandes MS, Fernandes MS, Hulstijn M, Hulstijn M, Lithio A, Lithio A, Nacerddine K, Nacerddine K, Agarwal N, Agarwal N
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
Lancet Oncol. 2025;26(11). PMID: 41167216.
Associations of Critical Relationships With Distress and Burden in Caregivers of Patients With Brain Tumor.
Reblin M, Reblin M, Wells KJ, Wells KJ, Zebrack BJ, Zebrack BJ, Witte D, Witte D, Byrne MM, Byrne MM
Associations of Critical Relationships With Distress and Burden in Caregivers of Patients With Brain Tumor.
Psychooncology
Psychooncology. 2025;34(11). PMID: 41198147; PMCID: PMC12591926.
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy.
Nelson KJ, Nelson KJ, Smalley TL, Smalley TL, Messier T, Messier T, Gumpena R, Gumpena R, Gandhi U, Gandhi U, Milczarek S, Milczarek S, Habibovic A, Habibovic A, Hoffman H, Hoffman H, Gibson V, Gibson V, Hondal RJ, Hondal RJ, Lowther WT, Lowther WT, Cunniff B, Cunniff B
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy.
Sci Adv
Sci Adv. 2025;11(44). PMID: 41171914; PMCID: PMC12577686.
Cancer Burden in Persistent Poverty Areas across the Cancer Continuum: A Scoping Review to Identify Gaps and Opportunities for Future Research.
Hallgren E, Hallgren E, Hallgren E, DelNero P, DelNero P, DelNero P, Owsley K, Owsley KM, Owsley K, Strahan K, Strahan K, Strahan K, Allen JL, Allen JL, Allen JL, Amick BC, Amick BC, Amick BC, Schootman M, Schootman M, Schootman M
Cancer Burden in Persistent Poverty Areas across the Cancer Continuum: A Scoping Review to Identify Gaps and Opportunities for Future Research.
Cancer Epidemiol Biomarkers Prev
Cancer Epidemiol Biomarkers Prev. 2025. PMID: 41159938.
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.
Ahmed N, Ahmed N, Thiruvengadam SK, Thiruvengadam SK, Hamadani M, Hamadani M, Hu ZH, Hu ZH, Grover N, Grover N, Shadman M, Shadman M, Locke FL, Locke FL, Gerson J, Gerson J, Frank MJ, Frank MJ, Budde LE, Budde LE, Wang M, Wang M, Kim S, Kim S, Bye M, Bye M, Kharfan-Dabaja MA, Kharfan-Dabaja MA, Sauter C, Sauter C, Hematti P, Hematti P, Turtle CJ, Turtle CJ, Ahmed S, Ahmed S, Moskop A, Moskop A, Logan B, Logan B, Nunes A, Nunes A, Dalton D, Dalton D, Kloos I, Kloos I, Lee D, Lee D, Xu H, Xu H, Pasquini MC, Pasquini MC, Herrera AF, Herrera AF
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.
Blood Adv
Blood Adv. 2025;9(20). PMID: 40706035; PMCID: PMC12597645.
Hysteresis Curves: Scalable Measures of Lagged Conversation Events for Communication Science.
Dewoolkar AM, Dewoolkar AM, Bonson K, Bonson K, Rizzo DM, Rizzo DM, Gramling R, Gramling R
Hysteresis Curves: Scalable Measures of Lagged Conversation Events for Communication Science.
J Pain Symptom Manage
J Pain Symptom Manage. 2025. PMID: 41139046.
Artificial Intelligence (AI) Tools Have the Potential to Help Reduce False-Positive Rates of Screening Mammography in a Single-Reader AI-Assisted Workflow.
Perry H, Perry H, Perry H
Artificial Intelligence (AI) Tools Have the Potential to Help Reduce False-Positive Rates of Screening Mammography in a Single-Reader AI-Assisted Workflow.
AJR Am J Roentgenol
AJR Am J Roentgenol. 2025. PMID: 41123965.
Impact of hospital-acquired venous thromboembolism on surviving a medical admission: findings from the Medical Inpatient Thrombosis and Hemostasis Study.
Martin KA, Martin KA, Sparks AD, Sparks AD, Wilkinson K, Wilkinson K, Packer R, Packer R, Poston JN, Poston JN, Terrell DR, Terrell DR, Gergi M, Gergi M, Ferraris A, Ferraris A, Wood WA, Wood WA, Repp AB, Repp AB, Smith N, Smith N, Roetker NS, Roetker NS, Zakai NA, Zakai NA
Impact of hospital-acquired venous thromboembolism on surviving a medical admission: findings from the Medical Inpatient Thrombosis and Hemostasis Study.
J Thromb Haemost
J Thromb Haemost. 2025. PMID: 41135659; PMCID: PMC12673607.
Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.
Beaussant Y, Beaussant Y, Tarbi E, Tarbi E, Nigam K, Nigam K, Miner S, Miner S, Sager Z, Sager Z, Sanders J, Sanders J, Ljuslin M, Ljuslin M, Guérin B, Guérin B, Sholevar R, Sholevar R, Roddy K, Roddy K, Tulsky JA, Tulsky JA, Agrawal M, Agrawal M
Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.
Gen Hosp Psychiatry
Gen Hosp Psychiatry. 2025;97. PMID: 41109203.
Spatially Discontinuous Mutation Topographies in Ductal Carcinoma in Situ Reveal Non-Competitive Growth Dynamics.
Ryser MD, Ryser MD, Greenwald MA, Greenwald MA, Monyak D, Monyak D, Sorribes IC, Sorribes IC, King L, King L, Hall A, Hall A, Geradts J, Geradts J, Weaver DL, Weaver DL, Mallo D, Mallo D, Holloway ST, Holloway ST, Wu E, Wu E, Murgas KA, Murgas KA, West RB, West RB, Grimm LJ, Grimm LJ, Maley CC, Maley CC, Marks JR, Marks JR, Shibata D, Shibata D, Hwang ES, Hwang ES
Spatially Discontinuous Mutation Topographies in Ductal Carcinoma in Situ Reveal Non-Competitive Growth Dynamics.
Cancer Res
Cancer Res. 2025. PMID: 41066536.
Postdiagnosis Statin Use and Breast Cancer Mortality.
Harborg S, Pedersen L, Sørensen HT, Ahern TP, Cronin-Fenton D, Borgquist S
Postdiagnosis Statin Use and Breast Cancer Mortality.
JAMA Netw Open
JAMA Netw Open. 2025;8(10):e2538737. PMID: 41165708; PMCID: PMC12576488.
Artificial Intelligence for Serious Illness Communication: Proactive Approaches to Mitigating Harm.
Tarbi EC, Durieux BN, Kwok A, Rizzo DM, Lindvall C
Artificial Intelligence for Serious Illness Communication: Proactive Approaches to Mitigating Harm.
J Med Philos
J Med Philos. 2025. PMID: 41020796.
Cigarette smoking prevalence, nicotine dependence, and quit ratios among U.S. adult females by residence and military-veteran status: 2002-2023.
McDaniel JT, Redner R, Coleman SRM, Klemperer EM, Chen FF, Bolívar HA, Higgins ST
Cigarette smoking prevalence, nicotine dependence, and quit ratios among U.S. adult females by residence and military-veteran status: 2002-2023.
Prev Med
Prev Med. 2025. PMID: 41033470; PMCID: PMC12509234.
Effects of Prior Diagnosis on Second Opinions and Pathologist Viewing Behaviors: Results from a Randomized Trial in Breast Pathology.
Kerr KF, Eguchi MM, Shucard H, Drew T, Weaver DL, Elmore JG, Brunyé TT
Effects of Prior Diagnosis on Second Opinions and Pathologist Viewing Behaviors: Results from a Randomized Trial in Breast Pathology.
Med Decis Making
Med Decis Making. 2025. PMID: 41020455.
Mechano-osmotic signals control chromatin state and fate transitions in pluripotent stem cells.
McCreery KP, Stubb A, Stephens R, Fursova NA, Cook A, Kruse K, Michelbach A, Biggs LC, Keikhosravi A, Nykänen S, Pulkkanen R, Hydén-Granskog C, Zou J, Lackmann JW, Niessen CM, Vuoristo S, Miroshnikova YA, Wickström SA
Mechano-osmotic signals control chromatin state and fate transitions in pluripotent stem cells.
Nat Cell Biol
Nat Cell Biol. 2025;27(10):1757-1770. PMID: 41023488; PMCID: PMC12527910.
Nourishing lung health: a meta-analysis and systematic review protocol of nutrition interventions for lung cancer patients.
Bhurosy T, Lefevre C, Syeda Z
Nourishing lung health: a meta-analysis and systematic review protocol of nutrition interventions for lung cancer patients.
Syst Rev
Syst Rev. 2025;14(1). PMID: 41013762; PMCID: PMC12466066.
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.
Sajisevi M, Nguyen K, Callas P, Holcomb AJ, Vural E, Davis KP, Thomas CM, Stein JS, Asarkar A, Aulet R, Bell RK, Blasco MA, Bowmaster VB, Burruss CP, Chung J, Chan K, Chang BA, Coffey CS, Cognetti DM, Cooper DJ, Cordero J, Donovan J, Du YJ, Dundar Y, Dedivitis R, Edwards H, Erovic BM, Eskander A, Feinberg PA, Garvey EA, Goldstein D, Goodman JF, Goulart RN, Goyal N, Grasl S, Giurintano J, Gupta N, Habib A, Hackman T, Hara JH, Henson C, Hinni ML, Hua N, Johnson-Obaseki S, Juloori A, Kalman NS, Kejner A, Khaja SF, Ku JA, Lambert A, Luu BK, Magliocca KR, Medina LR, Michael C, Miles B, de GM, Moore MG, Morand GB, Moura K, Noroozi H, Patel R, Paydarfar J, Plonowska-Hirschfeld KA, Sadeghi N, Savaria F, Schmitt NC, Shapiro J, Shaver TB, Stoeckli SJ, Stokes WA, Sulibhavi A, Tasoulas J, Vendra V, Vinh DB, Virgen CG, Woody NM, Young GD, Kakarala K, Enepekides DJ, Hier MP, Davies L, Ryan WR
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.
Laryngoscope Investig Otolaryngol
Laryngoscope Investig Otolaryngol. 2025;10(5). PMID: 40995062; PMCID: PMC12455896.
Characterizing the mutational landscape of sinonasal squamous cell carcinoma using whole-exome sequencing.
Vareta JA, Zhang X, Kuhnell D, Hagen MC, Takiar V, Wise-Draper TM, Casper KA, Rodriguez-Ramirez P, Dragon JA, Langevin SM
Characterizing the mutational landscape of sinonasal squamous cell carcinoma using whole-exome sequencing.
Oral Oncol
Oral Oncol. 2025;169. PMID: 40972435.
Effects of very low nicotine content cigarettes and concurrent provision of e-cigarettes on symptoms of depression and anxiety.
Nolder KA, Gaalema DE, Katz BR, Tidey JW, Sigmon SC, Heil SH, Lee DC, DeSarno M, Klemperer EM, Menson KE, Cioe PA, Plucinski S, Wiley RC, Higgins ST
Effects of very low nicotine content cigarettes and concurrent provision of e-cigarettes on symptoms of depression and anxiety.
Exp Clin Psychopharmacol
Exp Clin Psychopharmacol. 2025. PMID: 40965925.
Asciminib and inotuzumab ozogamicin: a new combination for highly refractory Ph-positive B-cell acute lymphoblastic leukemia.
Strumilowska A, Devitt K, Conant J, Gardner JA, Volaric A, Hegde N, Adrianzen-Herrera D
Asciminib and inotuzumab ozogamicin: a new combination for highly refractory Ph-positive B-cell acute lymphoblastic leukemia.
Leuk Res Rep
Leuk Res Rep. 2025;24. PMID: 41036242; PMCID: PMC12482290.
The EBV-Positive Tumor Methylome Is Distinct from EBV-Negative in Diffuse Large B-Cell Lymphoma.
Volaric AK, Barrantes-Reynolds R, Sahakyan K, Fedoriw Y, Frietze S
The EBV-Positive Tumor Methylome Is Distinct from EBV-Negative in Diffuse Large B-Cell Lymphoma.
Cancers (Basel)
Cancers (Basel). 2025;17(18). PMID: 41008837; PMCID: PMC12468171.
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.
Crouchet E, Schaeffer E, Oudot MA, Moehlin J, Gadenne C, Jühling F, El H, Fujiwara N, Zhu S, Akter F, Durand SC, Charlot A, Ponsolles C, Martin R, Brignon N, Del F, Meiss-Heydmann L, Parnot M, Hamdane N, Heide D, Hetzer J, Heikenwälder M, Felli E, Pessaux P, Pochet N, Zoll J, Cunniff B, Hoshida Y, Mailly L, Baumert TF, Schuster C
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models.
J Clin Invest
J Clin Invest. 2025;135(21). PMID: 40932790; PMCID: PMC12578407.
Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity.
Yeon M, Yeon M, Perego M, Perego M, Elokely KM, Elokely KM, Abou-Gharbia M, Abou-Gharbia M, Childers WE, Childers WE, Milcarek AT, Milcarek AT, Bertolini I, Bertolini I, Tang HY, Tang HY, Languino LR, Languino LR, Stein GS, Stein GS, Ghule PN, Ghule PN, Vietje BP, Vietje BP, Taatjes DT, Taatjes DT, Altieri DC, Altieri DC
Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity.
Cancer Res
Cancer Res. 2025. PMID: 40928938; PMCID: PMC12495980.
Participation in cancer survivorship survey research: Differences by rurality and age.
Hallgren E, Caldwell AR, Andersen JA, Ason M, Selig JP, Langner J, McElfish PA
Participation in cancer survivorship survey research: Differences by rurality and age.
J Clin Transl Sci
J Clin Transl Sci. 2025;9(1). PMID: 41069353; PMCID: PMC12505241.
Early adipose tissue wasting in a preclinical model of human lung cancer cachexia.
Snoke DB, van JL, Bellafleur ER, Dearborn JS, Lenahan SM, Beal AE, Aboushousha R, Heininger SCJ, Ather JL, Mank MM, Sarausky H, Stephenson D, Reisz JA, D'Alessandro A, Majumdar D, Ahern TP, Xu K, Sandler KL, Landman BA, Janssen-Heininger YMW, Poynter ME, Seward DJ, Toth MJ
Early adipose tissue wasting in a preclinical model of human lung cancer cachexia.
Cell Rep
Cell Rep. 2025;44(9). PMID: 40934088; PMCID: PMC12505381.
Investigating the substitutability of little cigars/cigarillos, e-cigarettes, and other noncombusted tobacco products for cigarettes using the experimental tobacco marketplace.
Feinstein MJP, Erath TG, Thrailkill EA, DeSarno MJ, Medina N, Freitas-Lemos R, Higgins ST, Klemperer EM
Investigating the substitutability of little cigars/cigarillos, e-cigarettes, and other noncombusted tobacco products for cigarettes using the experimental tobacco marketplace.
Exp Clin Psychopharmacol
Exp Clin Psychopharmacol. 2025. PMID: 40920542.
Training and Preparedness among Informal Cancer Caregivers.
Hallgren E, Andersen JA, Thompson T, King D, Moore R, Ason M, Council SK, Wahls A, McElfish PA
Training and Preparedness among Informal Cancer Caregivers.
Support Care Cancer
Support Care Cancer. 2025;33(9). PMID: 40858762.
Palliative Chemotherapy is Well Tolerated in a Patient With Metastatic Colorectal Cancer Due to Bloom Syndrome With a Novel BLM Mutation.
Baca J, Anderson K, Lahiri T, Sybenga A, Higgins T, Heath JL
Palliative Chemotherapy is Well Tolerated in a Patient With Metastatic Colorectal Cancer Due to Bloom Syndrome With a Novel BLM Mutation.
J Pediatr Hematol Oncol
J Pediatr Hematol Oncol. 2025. PMID: 40833085.
Assessing social support networks in cancer survivors and their care partners: concordance between expected and received support.
Cloyes KG, Guo JW, Mansfield KJ, Nowak S, Reblin M
Assessing social support networks in cancer survivors and their care partners: concordance between expected and received support.
J Cancer Surviv
J Cancer Surviv. 2025. PMID: 40830722.
Single-center retrospective analysis of the impact of rurality on glioblastoma care in Vermont.
Valentin GS, D'Agostino E, Callas P, Thomas AA
Single-center retrospective analysis of the impact of rurality on glioblastoma care in Vermont.
BMC Health Serv Res
BMC Health Serv Res. 2025;25(1). PMID: 40783532; PMCID: PMC12335795.
Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases.
Anders C, Neuberger E, Schwartz NRM, Bartley K, Wang S, Liu Y, Pittner BT, Kaufman PA, Meisel J
Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases.
Int J Clin Oncol
Int J Clin Oncol. 2025;30(10). PMID: 40768012; PMCID: PMC12474727.
Guiding principles for adult CNS tumor treatment programs.
Rock V, Ahluwalia MS, Anthony M, Arons D, Arzbaecher J, Dunbar E, Fraher C, Freund M, Gondi V, Khanuja S, Leach D, Loughan AR, Musella A, Oliver K, Paabo K, Puduvalli VK, Shaffer GD, Thomas AA, Wallgren K, Wefel JS, Yu JS, Zada G, Willmarth N, DeVitto R
Guiding principles for adult CNS tumor treatment programs.
Neurooncol Adv
Neurooncol Adv. 2025;7(1). PMID: 40980442; PMCID: PMC12448407.
Primary secretory carcinoma of thyroid with unusual features mimicking metastasis?
Teague J, Ciolino A, Sajisevi M
Primary secretory carcinoma of thyroid with unusual features mimicking metastasis?
Diagn Pathol
Diagn Pathol. 2025;20(1). PMID: 40739667; PMCID: PMC12312264.
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
Shah N, Suchanek M, Thakkar A, Patel RJ, Rahman S, Acuna-Villaorduna A, Shah U, Adrianzen Herrera D, Slasky S, Gritsman K, Goldfinger M, Shastri A, Mantzaris I, Kornblum N, Bachier-Rodriguez L, Feldman E, Cooper D, McNeill KA, Wang Y, Shi Y, Verma A, Ye BH, Janakiram M, Sica RA
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
JCO Precis Oncol
JCO Precis Oncol. 2025;9:e2300526. PMID: 40712110; PMCID: PMC12309975.
Examining US adolescent cigarette smoking prevalence by rurality and gender, 2002-2019.
Erath TG, Chen FF, DeSarno M, Higgins ST
Examining US adolescent cigarette smoking prevalence by rurality and gender, 2002-2019.
Prev Med
Prev Med. 2025. PMID: 40716718; PMCID: PMC12366418.
Pre-Surgical Education and Discharge Planning for Head and Neck Cancer: A Qualitative Study of Patient and Caregiver Perspectives.
Basta A, Mikhael M, Kansara B, Hume E, Nguyen OT, Reblin M, Tabriz AA, Hong YR, Magnuson JS, Patel K, Turner K
Pre-Surgical Education and Discharge Planning for Head and Neck Cancer: A Qualitative Study of Patient and Caregiver Perspectives.
Cancer Control
2025 Jan-Dec:32:10732748251331979.doi: 10.1177/10732748251331979.Epub 2025 Apr 14. PMID: 40228315; PMCID: PMC12033563.
Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up.
Solmunde E, Pedersen RN, Nørgaard M, Mellemkjær L, Friis S, Ejlertsen B, Ahern TP, Cronin-Fenton DP
Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up.
Br J Cancer
Br J Cancer. 2025;133(6). PMID: 40691279; PMCID: PMC12449462.
Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study.
Zakai NA, Wilkinson K, Sparks AD, Packer RT, Roetker NS, Repp AB, Gergi M, Holmes C, Cushman M, Plante TB, Al-Samkari H, Pishko AM, Wood WA, Masias C, Gangaraju R, Li A, Garcia D, Wiggins KL, Schaefer JK, Smith NL, Ferraris A, Martin KA, Terrell DR, McClure LA
Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study.
J Thromb Haemost
J Thromb Haemost. 2025. PMID: 40683552; PMCID: PMC12329860.
Epigenome-wide association study of gestational exposure to organophosphate esters and replacement brominated flame retardants with newborn DNA methylation.
Mendy A, Percy Z, Braun JM, Lanphear B, La MJ, Hale RC, Langevin S, Kelsey K, Chen A, Yolton K
Epigenome-wide association study of gestational exposure to organophosphate esters and replacement brominated flame retardants with newborn DNA methylation.
Sci Total Environ
Sci Total Environ. 2025;995. PMID: 40680372.
Examining rural disparities in cigarette smoking among U.S. women by chronological age: 2002-2022.
Higgins ST, Erath TG, Chen FF, DeSarno MJ
Examining rural disparities in cigarette smoking among U.S. women by chronological age: 2002-2022.
Prev Med
Prev Med. 2025. PMID: 40653176; PMCID: PMC12317656.
Epigenomic Modulators and Thyroid Hormone Receptor β Agonists: A New Paradigm for Tumor Suppression in Thyroid Cancer.
Rustad JL, Gillis NE, Lignos J, Bright KA, Frietze S, Carr FE
Epigenomic Modulators and Thyroid Hormone Receptor β Agonists: A New Paradigm for Tumor Suppression in Thyroid Cancer.
Endocrinology
Endocrinology. 2025;166(9). PMID: 40658739; PMCID: PMC12290509.
E-cigarette use frequency mediates effects in three randomized controlled trials of reduced nicotine cigarettes with tobacco vs preferred flavor E-cigarettes in high-risk populations in the U.S.
Klemperer EM, DeSarno MJ, Tidey JW, Gaalema DE, Nolder KA, Feinstein MJP, Wiley RC, Higgins ST
E-cigarette use frequency mediates effects in three randomized controlled trials of reduced nicotine cigarettes with tobacco vs preferred flavor E-cigarettes in high-risk populations in the U.S.
Prev Med
Prev Med. 2025. PMID: 40628358; PMCID: PMC12291598.
Pilot randomized clinical trial examining use of very low nicotine content cigarettes during pregnancy in the United States.
Heil SH, Kock LS, Harfmann RF, Ashford KB, Barnett J, McCubbin A, DeSarno MJ, Higgins ST
Pilot randomized clinical trial examining use of very low nicotine content cigarettes during pregnancy in the United States.
Prev Med
Prev Med. 2025. PMID: 40623557; PMCID: PMC12305679.
Engineered Lactiplantibacillus plantarum WCFS1 as a Biosensor Probe for Lung Cancer.
Brasino M, Wagnell E, Manalo EC, Drennan S, Fischer JM, Merritt J
Engineered Lactiplantibacillus plantarum WCFS1 as a Biosensor Probe for Lung Cancer.
ACS Synth Biol
ACS Synth Biol. 2025;14(7):2774-2787. PMID: 40607508.
Anapc5 and Anapc7 as genetic modifiers of KIF18A function in fertility and mitotic progression.
Nesbit C, Martin W, Czechanski A, Byers C, Raghupathy N, Ferraj A, Stumpff J, Reinholdt L
Anapc5 and Anapc7 as genetic modifiers of KIF18A function in fertility and mitotic progression.
Sci Rep
Sci Rep. 2025;15(1). PMID: 40596695; PMCID: PMC12214974.
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines.
Kennedy T, Singh S, Abood G, Christenson E, Anker CJ, Akselrod D, Hallemeier CL, Jethwa KR, Kim E, Lee P, Miller ED, Newman NB, Selfridge JE, Sharma N, Small W, Tchelebi L, Williams VM, Russo S
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines.
Cancer Med
Cancer Med. 2025;14(14). PMID: 40693544; PMCID: PMC12281213.
Report of Active Surveillance for a Masson Tumor of Chest Wall With Spontaneous Resolution.
Mohardt ML, Kennedy JM, Lemos DF, Kooperkamp H, Cintolo-Gonzalez JA
Report of Active Surveillance for a Masson Tumor of Chest Wall With Spontaneous Resolution.
Thorac Cancer
Thorac Cancer. 2025;16(13). PMID: 40590274; PMCID: PMC12210035.
Utilization Patterns and Outcomes From Iron Chelation Therapy in Elderly Patients With Myelodysplastic Syndromes: A Population Analysis.
Strumilowska A, Sparks A, Zakai N, Adrianzen D
Utilization Patterns and Outcomes From Iron Chelation Therapy in Elderly Patients With Myelodysplastic Syndromes: A Population Analysis.
Clin Lymphoma Myeloma Leuk
2025 Jun 27:S2152-2650(25)00236-8. doi: 10.1016/j.clml.2025.06.020. Online ahead of print. PMID: 40713402.
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer: Systematic Review and Guidelines.
Russo S, Anker CJ, Codipilly DC, Abood G, Akselrod D, Hallemeier CL, Jethwa KR, Jin Z, Kim E, Kennedy T, Lee P, Miller ED, Newman NB, Selfridge JE, Sharma N, Small W, Tchelebi L, Williams VM, Simone CB
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer: Systematic Review and Guidelines.
Am J Clin Oncol
2025 Jun 25.doi: 10.1097/COC.0000000000001222.Online ahead of print. PMID: 40557604.
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Bran I, Vasconcelos G, Hughes BGM, Oliva M, Pinto I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D, KEYNOTE-689 Investigators
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
N Engl J Med
2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. PMID: 40532178.
Mammographic calcifications association with risk of advanced breast cancer.
Kerlikowske K, Abraham L, Sprague BL, Sattayapiwat O, Nyante SJ, Tice JA, Miglioretti DL
Mammographic calcifications association with risk of advanced breast cancer.
Breast Cancer Res Treat
2025 Aug;212(3):555-567.doi: 10.1007/s10549-025-07753-z.Epub 2025 Jun 17. PMID: 40526234; PMCID: PMC12209027.
Association of intraindividual variability in simple reaction time with balance and falls in older cancer survivors: A secondary analysis.
McNeish BL, Shores CMS, Bell SG, Dittus K, Mossburg J, Krant N, Steinharter JA, Feb K, Hehir MK, Redfern MS, Rosano C, Richardson JK, Kolb N
Association of intraindividual variability in simple reaction time with balance and falls in older cancer survivors: A secondary analysis.
J Geriatr Oncol
2025 Jun 13;16(6):102288.doi: 10.1016/j.jgo.2025.102288.Online ahead of print. PMID: 40516230.
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.
Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research. 2025;31(12) PMID: 40192715; PMCID: PMC11371093.
Caregiving in rural areas: A qualitative study of challenges and resilience.
Choi H, Vatovec C, Reblin M
Caregiving in rural areas: A qualitative study of challenges and resilience.
PLoS One
2025 Jun 6;20(6):e0325536.doi: 10.1371/journal.pone.0325536.eCollection 2025. PMID: 40478859; PMCID: PMC12143517.
Genome-wide maps of UV damage repair and mutation suppression by CPD photolyase.
Bohm KA, Laughery MF, Mieczkowski PA, Roberts SA, Curation JJWD
Genome-wide maps of UV damage repair and mutation suppression by CPD photolyase.
Nucleic Acids Res
Nucleic acids research. 2025;53(11) PMID: 40498072; PMCID: PMC419797.
Embracing Compassion for People Facing Lung Cancer-the American Cancer Society National Lung Cancer Roundtable.
Studts JL, Carter-Bawa L, Feldman J, Schiller JH, Scharnetzki E, Pantelas J, Manley E, Williamson TJ, Rivera MP, Sakoda LC, Wood D, Kazerooni EA, Rosenthal LS, Smith RA, Moghanaki D
Embracing Compassion for People Facing Lung Cancer-the American Cancer Society National Lung Cancer Roundtable.
Ann Intern Med
2025 Jun 3.doi: 10.7326/ANNALS-24-03167.Online ahead of print. PMID: 40456158.
Colorectal cancer survival disparities in persistent poverty areas.
DelNero P, Schootman M, Peng C, Saini M, Hallgren E, Laryea J, Li C
Colorectal cancer survival disparities in persistent poverty areas.
J Rural Health
2025 Jun;41(3):e70045.doi: 10.1111/jrh.70045. PMID: 40629554.
A factorial randomized clinical trial of nicotine replacement therapy and treatment recommendations to quit vs continue e-cigarettes when quitting smoking in young adult dual users.
Klemperer EM, Klemperer EM, Feinstein MJP, Feinstein MJP, Marsh K, Marsh K, Villanti AC, Villanti AC, Carpenter MJ, Carpenter MJ, Skelly JM, Skelly JM, DeSarno MJ, DeSarno MJ, Higgins ST, Higgins ST
A factorial randomized clinical trial of nicotine replacement therapy and treatment recommendations to quit vs continue e-cigarettes when quitting smoking in young adult dual users.
Nicotine Tob Res
2025 May 31:ntaf119.doi: 10.1093/ntr/ntaf119.Online ahead of print. PMID: 40448340.
Beyond survival: food insecurity challenges for survivors of cancer post-COVID.
Bhurosy T, Abraham FO, Reblin M, Niu Z, Chung T
Beyond survival: food insecurity challenges for survivors of cancer post-COVID.
Cancer Causes Control
2025 May 29.doi: 10.1007/s10552-025-02016-0.Online ahead of print. PMID: 40439981.
Characterizing Interpretive and Diagnostic Competency Development in Pathology Training.
Brunyé TT, Shucard H, Eguchi MM, Drew T, Marotti J, Lomo LC, Kilgore MR, Allison KH, Kerr KF, Elmore JG, Weaver DL
Characterizing Interpretive and Diagnostic Competency Development in Pathology Training.
Mod Pathol
2025 May 27:100802.doi: 10.1016/j.modpat.2025.100802.Online ahead of print. PMID: 40441531.
Role of Slc7a11 in Bleomycin-Induced Lung Injury.
Ritzenthaler JD, Torres-Gonzalez E, Janssen-Heininger Y, Watson WH, Roman J
Role of Slc7a11 in Bleomycin-Induced Lung Injury.
Lung
2025 May 26;203(1):64.doi: 10.1007/s00408-025-00818-2. PMID: 40419688.
Making 3' ends meet.
Doublié S
Making 3' ends meet.
Nat Struct Mol Biol
2025 May 22.doi: 10.1038/s41594-025-01578-6.Online ahead of print. PMID: 40404983.
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patients.
Woolpert KM, Ahern TP, Baurley JW, Maliniak ML, Damkier P, Kjærsgaard A, Collin LJ, Hamilton-Dutoit S, Tramm T, Ejlertsen B, Sørensen HT, Lash TL, Cronin-Fenton DP
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patients.
Breast Cancer Res Treat
2025 Jul;212(2):251-260.doi: 10.1007/s10549-025-07719-1.Epub 2025 May 14. PMID: 40369345; PMCID: PMC12134019.
Unraveling the role of stromal disruption in aggressive breast cancer etiology and outcomes.
Abubakar M, Duggan MA, Fan S, Pfeiffer RM, Lawrence S, Mutreja K, Klein A, Koka H, Ahearn TU, Henry JE, Sprague BL, Vacek PM, Weaver DL, Richert-Boe K, Kimes TM, Titiloye N, Edusei L, Figueroa JD, Yang XR, Garcia-Closas M, Rohan TE, Gierach GL
Unraveling the role of stromal disruption in aggressive breast cancer etiology and outcomes.
J Natl Cancer Inst
2025 May 14:djaf070.doi: 10.1093/jnci/djaf070.Online ahead of print. PMID: 40366376.
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
N Engl J Med
2025 May 8;392(18):1824-1835.doi: 10.1056/NEJMoa2408771. PMID: 40334157.
Social Needs in Cancer Survivors: A Scoping Review and Future Directions.
Thompson T, Doherty M, Berrett-Abebe J, Brown C, Hallgren E, Kirk S, Weal R, Chauhan K, Cadet TJ
Social Needs in Cancer Survivors: A Scoping Review and Future Directions.
Curr Oncol Rep
2025 Jun;27(6):717-733.doi: 10.1007/s11912-025-01664-4.Epub 2025 May 5. PMID: 40323567; PMCID: 8494398.
Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma.
Mejía-García A, Orozco CA, Herzog J, Alarcón-Betancourth O, Meneses-Torres A, Ramírez M, González J, Zambrano Y, Combita AL, Bonilla DA, Frietze S
Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma.
Int J Mol Sci
International journal of molecular sciences. 2025;26(9) PMID: 40362553; PMCID: PMC7998712.
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach.
Woolpert KM, Cronin-Fenton DP, Damkier P, Kjærsgaard A, Hamilton-Dutoit S, Ejlertsen B, MacLehose RF, Christiansen P, Silliman RA, Lash TL, Ahern TP, Collin LJ
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach.
Pharmacoepidemiol Drug Saf
2025 May;34(5):e70157.doi: 10.1002/pds.70157. PMID: 40364655; PMCID: PMC12076038.
Stage at Diagnosis for Common Cancers According to Rurality, Area Deprivation and Insurance, 2017-2021.
Fairfield KM, Murray K, Cloutier LM, Daggett JL, Felix BR, Kapala CA, Fay-Leblanc RM, Nadeau AE, Rauscher BK, Rensenbrink K, Rothenberg DA, Stein KD
Stage at Diagnosis for Common Cancers According to Rurality, Area Deprivation and Insurance, 2017-2021.
Cancer Prev Res (Phila)
2025 Apr 30.doi: 10.1158/1940-6207.CAPR-24-0587.Online ahead of print. PMID: 40304380.
Sex-Specific Formation of 1,2:3,4-Diepoxybutane-Derived Hemoglobin Adducts in 1,3-Butadiene-Exposed Workers.
Georgieva NI, Siegel ER, Šrám RJ, Vacek PM, Walker VE, Albertini RJ, Swenberg JA, Boysen G
Sex-Specific Formation of 1,2:3,4-Diepoxybutane-Derived Hemoglobin Adducts in 1,3-Butadiene-Exposed Workers.
Chem Res Toxicol
2025 Apr 22.doi: 10.1021/acs.chemrestox.4c00530.Online ahead of print. PMID: 40261942.
Cardio-Oncology and Breast Cancer Therapies.
Singh R, Patel K, Xu H, Adeniyi A, Upshaw JN, Van Buren P, Kaufman PA, Dittus K, Landry KK
Cardio-Oncology and Breast Cancer Therapies.
Curr Treat Options Oncol
2025 May;26(5):385-397.doi: 10.1007/s11864-025-01311-x.Epub 2025 Apr 21. PMID: 40257669.
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incidence of Venous Thromboembolism in Older Adults.
Saadatagah S, Kim RB, Sukumar S, Uddin MM, Folsom AR, Cushman M, Tang W, Natarajan P, Ballantyne CM, Lutsey PL, Li A
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incidence of Venous Thromboembolism in Older Adults.
J Thromb Haemost
2025 Apr 17:S1538-7836(25)00255-7.doi: 10.1016/j.jtha.2025.03.042.Online ahead of print. PMID: 40252845.
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.
Borgquist S, Jensen MB, Bendorff CL, Christiansen P, Offersen BV, Kodahl AR, Ewertz M, Jensen AB, Ahern TP, Cronin-Fenton D, Ejlertsen B
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.
Clin Epidemiol
2025 Apr 17:17:409-419.doi: 10.2147/CLEP.S509873.eCollection 2025. PMID: 40260427; PMCID: PMC12011050.
Advancements in Prostate Cancer Radiotherapy: The Role of PSMA PET Imaging.
Lester-Coll NH, Dal Pra A, Murthy V, Kamran SC
Advancements in Prostate Cancer Radiotherapy: The Role of PSMA PET Imaging.
Pract Radiat Oncol
2025 Apr 15:S1879-8500(25)00073-6.doi: 10.1016/j.prro.2025.03.008.Online ahead of print. PMID: 40246072.
"The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
Blum AC, Tessema R, Nussbaum L, Hidalgo C, López EJR, Sánchez GM, Morse RM, Brown J, Reategui RR, Wong L, Córdova LD, Díaz KG, Liñán RL, Vásquez JV, Tracy JK, Paz-Soldan VA
"The problem is not detection, it is treatment": exploring why women needing pre-cervical cancer care are lost to follow-up at the hospital in Iquitos, Peru.
BMC Health Serv Res
2025 Apr 14;25(1):544.doi: 10.1186/s12913-025-12685-x. PMID: 40229789; PMCID: PMC11995470.
Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study.
Thomas RM, Sparks AD, Wilkinson K, Gergi M, Repp AB, Roetker NS, Smith NL, Muthukrishnan P, Martin K, Zakai NA
Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study.
J Thromb Haemost
2025 Apr 14:S1538-7836(25)00254-5.doi: 10.1016/j.jtha.2025.04.005.Online ahead of print. PMID: 40239812.
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.
Winchester DJ, Singh L, Edge SB, Allison KH, Barlow WE, Bossuyt V, Chavez-MacGregor M, Conant EF, Connolly JL, De Los Santos JF, Hayes DF, Hylton NM, Mittendorf EA, Plichta JK, Provenzano E, Salerno KE, Sharma P, Symmans WF, Weaver D, Hortobagyi GN
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.
J Clin Oncol
2025 Apr 11:JCO2401739.doi: 10.1200/JCO-24-01739.Online ahead of print. PMID: 40215445.
Diagnostic management pathways for workup of abnormal screening with digital mammography versus digital breast tomosynthesis.
Henderson LM, Zhu W, Onega T, Kerlikowske K, Miglioretti DL, Bowles EJA, Sprague BL, Weaver DL, Tosteson ScD ANA, Lee CI
Diagnostic management pathways for workup of abnormal screening with digital mammography versus digital breast tomosynthesis.
J Am Coll Radiol
2025 Apr 9:S1546-1440(25)00207-8.doi: 10.1016/j.jacr.2025.04.008.Online ahead of print. PMID: 40216286.
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
Jhaveri K, Anders CK, Bardia A, Bhave M, Chien AJ, Krop I, Traina TA, Abdou Y, Basho R, Conlin AK, Esteva FJ, Fox KR, Gadi V, Kaufman PA, Litvak A, Ma CX, Mamounas EP, McArthur H, McCann K, Mitri Z, Shatsky R, Telli M, Torres MA, Kalinsky K
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
Clin Breast Cancer
2025 Apr 8:S1526-8209(25)00098-9.doi: 10.1016/j.clbc.2025.04.007.Online ahead of print. PMID: 40340127.
Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition.
Cordova Sanchez A, Holmes CE, Dauerman HL, Gupta T
Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition.
J Thromb Thrombolysis
2025 Apr;58(4):538-546.doi: 10.1007/s11239-025-03092-4.Epub 2025 Apr 1. PMID: 40167885.
BIO25-024: Real-Time Clinical Trial Data Library in Non-Small Cell Lung (NSCLC), Prostate (PC), and Breast Cancer (BC) to Support Informed Treatment Decisions: Now a Reality With a Fine-Tuned Large Language Model (LLM).
Liu RJ, Forsythe A, Rege JM, Kaufman P
BIO25-024: Real-Time Clinical Trial Data Library in Non-Small Cell Lung (NSCLC), Prostate (PC), and Breast Cancer (BC) to Support Informed Treatment Decisions: Now a Reality With a Fine-Tuned Large Language Model (LLM).
J Natl Compr Canc Netw
2025 Mar 28;23(3.5):BIO25-024.doi: 10.6004/jnccn.2024.7156. PMID: 40157350.
Mammography Screening by Age in the United States-Too Little and Too Much?
Trentham-Dietz A, Sprague BL
Mammography Screening by Age in the United States-Too Little and Too Much?
Ann Intern Med
2025 Mar 25.doi: 10.7326/ANNALS-25-00477.Online ahead of print. PMID: 40127445.
Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study.
Gergi M, Wilkinson K, Sparks A, Roetker NS, Al-Samkari H, Smith NL, Plante TB, Cushman M, Repp AB, Holmes CE, Martin K, Zakai NA
Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study.
J Thromb Haemost
2025 Mar 21:S1538-7836(25)00186-2.doi: 10.1016/j.jtha.2025.02.044.Online ahead of print. PMID: 40122464.
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH, COMET Study Investigators
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
JAMA
2025 Mar 18;333(11):972-980. doi: 10.1001/jama.2024.26698 PMID: 39665585; PMCID: PMC4260649.
Metabolic profiling of adult and pediatric gliomas reveals enriched glucose availability in pediatric gliomas and increased fatty acid oxidation in adult gliomas.
Sviderskiy VO, Vasudevaraja V, Dubois LG, Stafford J, Liu EK, Serrano J, Possemato R, Snuderl M
Metabolic profiling of adult and pediatric gliomas reveals enriched glucose availability in pediatric gliomas and increased fatty acid oxidation in adult gliomas.
Acta Neuropathol Commun
2025 Mar 15;13(1):61.doi: 10.1186/s40478-025-01961-w. PMID: 40087788; PMCID: PMC11909955.
Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria.
Bergquist T, Stenton SL, Nadeau EAW, Byrne AB, Greenblatt MS, Harrison SM, Tavtigian SV, O'Donnell-Luria A, Biesecker LG, Radivojac P, Brenner SE, Pejaver V
Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria.
Genet Med
2025 Mar 10:101402.doi: 10.1016/j.gim.2025.101402.Online ahead of print. PMID: 40084623.
Functional Characterization of a Genetic Variant in the 5' UTR of APC 1B Promoter in a Familial Adenomatous Polyposis Family.
Young B, Neklason DW, Clark K, Feng BJ, Keener MB, Tuohy TM, Wood A, McKinnon WC, Greenblatt MS, Tavtigian SV
Functional Characterization of a Genetic Variant in the 5' UTR of APC 1B Promoter in a Familial Adenomatous Polyposis Family.
Am J Med Genet A
2025 Mar 10:e63992.doi: 10.1002/ajmg.a.63992.Online ahead of print. PMID: 40062631.
Novel method of paraffin embedding cultured cells and organoids using silicone molds.
Lee K, Kittell J, Pierre HS, Crowley L, Stein JL, Stein GS, Ghule PN
Novel method of paraffin embedding cultured cells and organoids using silicone molds.
Histochem Cell Biol
2025 Mar 8;163(1):37.doi: 10.1007/s00418-025-02368-3. PMID: 40057580.
Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes A Secondary Analysis of a Naturalistic Randomized Clinical Trial.
Carpenter MJ, Smith TT, Walters KJ, Wahlquist AE, Koval KR, Klemperer EM
Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes A Secondary Analysis of a Naturalistic Randomized Clinical Trial.
Nicotine Tob Res
2025 Mar 4:ntaf055.doi: 10.1093/ntr/ntaf055.Online ahead of print. PMID: 40037836.
Corrigendum to 'Prospective solutions to ovarian reserve damage during the ovarian tissue cryopreservation and transplantation procedure' [Fertility and Sterility 122 (2024) 565-573].
Mercier A, Johnson J, Kallen AN
Corrigendum to 'Prospective solutions to ovarian reserve damage during the ovarian tissue cryopreservation and transplantation procedure' [Fertility and Sterility 122 (2024) 565-573].
Fertil Steril
2025 Apr;123(4):744.doi: 10.1016/j.fertnstert.2024.12.021.Epub 2025 Mar 3. PMID: 40047740.
Financial Rewards for Smoking Cessation During Pregnancy and Birth Weight: A Meta-Analysis.
Tappin D, Lee J, McConnachie A, Kock L, Higgins ST, Heil SH, Berlin I, Ondersma SJ, Kee F, Bernstein I, Bauld L
Financial Rewards for Smoking Cessation During Pregnancy and Birth Weight: A Meta-Analysis.
JAMA Netw Open
2025 Mar 3;8(3):e250214.doi: 10.1001/jamanetworkopen.2025.0214. PMID: 40048164; PMCID: PMC11886724.
Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations.
Tarbi EC, Schuler SL, Ambrose N, Hutchinson RN, Reblin M, Cheung KL
Telehealth for the study of palliative care communication: opportunities, methodological challenges, and recommendations.
BMC Palliat Care
2025 Mar 3;24(1):55.doi: 10.1186/s12904-025-01700-x. PMID: 40033257; PMCID: PMC11874772.
Longitudinal associations between symptom burden and fall risks in older adults with a cancer history: Findings from the 2011-2015 National Health and Aging Trends Study.
Bae M, Gell NM
Longitudinal associations between symptom burden and fall risks in older adults with a cancer history: Findings from the 2011-2015 National Health and Aging Trends Study.
J Geriatr Oncol
2025 Feb 26;16(3):102212.doi: 10.1016/j.jgo.2025.102212.Online ahead of print. PMID: 40014900.
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.
Varone E, Retini M, Cherubini A, Chernorudskiy A, Marrazza A, Guidarelli A, Cagnotto A, Beeg M, Gobbi M, Fumagalli S, Bolis M, Guarrera L, Barbera MC, Grasselli C, Bleve A, Generali D, Milani M, Mari M, Salmona M, Piersanti G, Bottegoni G, Broggini M, Janssen-Heininger YMW, Cho J, Cantoni O, Zito E
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.
Cell Death Dis
2025 Feb 17;16(1):105.doi: 10.1038/s41419-025-07426-1. PMID: 39962052; PMCID: PMC11833095.
Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.
Chen Y, Lee K, Woo J, Kim DW, Keum C, Babbi G, Casadio R, Martelli PL, Savojardo C, Manfredi M, Shen Y, Sun Y, Katsonis P, Lichtarge O, Pejaver V, Seward DJ, Kamandula A, Bakolitsa C, Brenner SE, Radivojac P, O'Donnell-Luria A, Mooney SD, Jain S
Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.
Hum Genet
2025 Feb 12.doi: 10.1007/s00439-025-02726-0.Online ahead of print. PMID: 39934475.
Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia.
Thomas CJ, Porter D, Van Deerlin VM, Bhattacharyya S, Carvajal V, Kim J, Priore S, Yang G, Gerson JN, Barta SK
Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia.
Leuk Lymphoma
2025 Feb 8:1-4.doi: 10.1080/10428194.2025.2462950.Online ahead of print. PMID: 39921538.
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines.
Williams VM, Hallemeier CL, Jethwa KR, Selfridge JE, Shah P, Anker CJ, Abood G, Akselrod D, Berlin J, Kim E, Kennedy T, Lee P, Sharma N, William S, Tchelebi L, Russo S
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines.
Am J Clin Oncol
2025 Feb 6.doi: 10.1097/COC.0000000000001165.Online ahead of print. PMID: 39912327.
Single and multiple tobacco product use among people with disabilities: Findings from the National Health Interview Survey, 2019-2022.
Schulz JA, Ganz O, Rubenstein D, West JC, Klemperer EM
Single and multiple tobacco product use among people with disabilities: Findings from the National Health Interview Survey, 2019-2022.
Addict Behav
2025 May:164:108283.doi: 10.1016/j.addbeh.2025.108283.Epub 2025 Feb 5. PMID: 39923385; PMCID: PMC11878199.
Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography.
Lawson MB, Zhu W, Miglioretti DL, Onega T, Henderson LM, Rauscher GH, Kerlikowske K, Sprague BL, Bowles EJA, O'Meara ES, Tosteson ANA, diFlorio-Alexander RM, Hubbard RA, Lee JM, Lee CI
Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography.
Radiology
2025 Feb;314(2):e241673.doi: 10.1148/radiol.241673. PMID: 39964269; PMCID: PMC11868819.
Body composition alterations in patients with lung cancer.
Snoke DB, Atwood GS, Bellefleur ER, Stokes AM, Toth MJ
Body composition alterations in patients with lung cancer.
Am J Physiol Cell Physiol
2025 Jan 31.doi: 10.1152/ajpcell.01048.2024.Online ahead of print. PMID: 39887975.
The patient and caregiver experience of CAR T-cell therapy: A qualitative analysis.
Reblin M, Liang I, Tay DL, Kirtane K, Ketcher D
The patient and caregiver experience of CAR T-cell therapy: A qualitative analysis.
J Psychosoc Oncol
2025 Jan 30:1-11.doi: 10.1080/07347332.2025.2460060.Online ahead of print. PMID: 39883430.
"It's hard to talk to a computer, I get it": An exploratory analysis of clinician connection-building communication practices in rural telepalliative care encounters.
Tarbi EC, Ambrose N, Anderson EC, Hutchinson RN, Han PKJ, Reblin M, Gramling R
"It's hard to talk to a computer, I get it": An exploratory analysis of clinician connection-building communication practices in rural telepalliative care encounters.
PEC Innov
2025 Jan 25:6:100377.doi: 10.1016/j.pecinn.2025.100377.eCollection 2025 Jun. PMID: 39974585; PMCID: PMC11836516.
Characteristics and Survival of Secondary Acute Myeloid Leukemia From Myelodysplastic Syndromes in Older Adults: A Population Analysis.
Batra A, Sparks A, Singh R, Zakai NA, Herrera DA
Characteristics and Survival of Secondary Acute Myeloid Leukemia From Myelodysplastic Syndromes in Older Adults: A Population Analysis.
Clin Lymphoma Myeloma Leuk
2025 Jun;25(6):e417-e423.doi: 10.1016/j.clml.2025.01.012.Epub 2025 Jan 23. PMID: 39952850.
Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction.
Murphy CS, Fairfield H, DeMambro VE, Fadel S, Gartner CA, Karam M, Potts C, Rodriguez P, Qiang YW, Hamidi H, Guan X, Vary CPH, Reagan MR
Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction.
Mol Oncol
2025 Jan 23.doi: 10.1002/1878-0261.13794.Online ahead of print. PMID: 39853696.
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells.
Blanc KL, Dazzi F, English K, Farge D, Galipeau J, Horwitz EM, Kadri N, Krampera M, Lalu MM, Nolta J, Patel NM, Shi Y, Weiss DJ, Viswanathan S
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells.
Cytotherapy
2025 Jan 17:S1465-3249(25)00030-1.doi: 10.1016/j.jcyt.2025.01.005.Online ahead of print. PMID: 39864015.
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes.
Adrianzen-Herrera DA, Strumlowska A
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes.
Curr Hematol Malig Rep
2025 Jan 17;20(1):6.doi: 10.1007/s11899-025-00750-5. PMID: 39821758.
APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats.
Brown RE, Coxon M, Larsen B, Allison M, Chadha A, Mittelstadt I, Mertz TM, Roberts SA, Freudenreich CH
APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats.
Proc Natl Acad Sci U S A
2025 Jan 14;122(2):e2408179122.doi: 10.1073/pnas.2408179122.Epub 2025 Jan 7. PMID: 39772743; PMCID: PMC11745325.
Physician-dominated conversations: An analysis of illness understanding discussions among patients with advanced cancer.
Durieux BN, Zverev SR, Agaronnik ND, Davis J, Pollak KI, Tulsky JA, Tarbi E, Lindvall C
Physician-dominated conversations: An analysis of illness understanding discussions among patients with advanced cancer.
Patient Educ Couns
2025 Jan 2:133:108633.doi: 10.1016/j.pec.2024.108633.Online ahead of print. PMID: 39793420.
Targeting chromosomally unstable tumors with a selective KIF18A inhibitor.
Phillips AF, Zhang R, Jaffe M, Schulz R, Carty MC, Verma A, Feinberg TY, Arensman MD, Chiu A, Letso R, Bosco N, Queen KA, Racela AR, Stumpff J, Andreu-Agullo C, Bettigole SE, Depetris RS, Drutman S, Su SM, Cogan DA, Eng CH
Targeting chromosomally unstable tumors with a selective KIF18A inhibitor.
Nat Commun
2025 Jan 2;16(1):307.doi: 10.1038/s41467-024-55300-z. PMID: 39747049; PMCID: PMC11697083.
Acetylation-Mediated Epigenetic Consequences for Biological Control and Cancer.
Fritz AJ, McKay KT, Greenyer HW, Pacht E, Toor RH, Ullah R, Del Porto JR, Person AG, Korzec SJ, Bright KE, Brzoza G, Heath JL, Ghule PN, Gordon JAR, Van Wijnen AJ, Frietze SE, Glass KC, Lian JB, Stein JL, Stein GS
Acetylation-Mediated Epigenetic Consequences for Biological Control and Cancer.
Results Probl Cell Differ
Results and problems in cell differentiation. 2025;75() PMID: 40593206; PMCID: 7658393.
Charting the Genomic Frontier: 25 Years of Evolution and Future Prospects in Molecular Diagnostics for Solid Tumors.
Hechtman JF, Baskovich B, Fussell A, Geiersbach KB, Iorgulescu JB, Sirohi D, Snow A, Sidiropoulos N
Charting the Genomic Frontier: 25 Years of Evolution and Future Prospects in Molecular Diagnostics for Solid Tumors.
J Mol Diagn
2025 Jan;27(1):6-11.doi: 10.1016/j.jmoldx.2024.08.010. PMID: 39722285.
Defining APOBEC-induced mutation signatures and modifying activities in yeast.
Mertz TM, Kockler ZW, Coxon M, Cordero C, Raval AK, Brown AJ, Harcy V, Gordenin DA, Roberts SA
Defining APOBEC-induced mutation signatures and modifying activities in yeast.
Methods Enzymol
Methods in enzymology. 2025;713() PMID: 40250951.
Evaluating community engagement efforts in a clinical and translational research initiative.
Waters KF, Joly B, Gray CE, Carney JK, Fairfield KM
Evaluating community engagement efforts in a clinical and translational research initiative.
J Clin Transl Sci
Journal of clinical and translational science. 2025;9(1) PMID: 40665967; PMCID: PMC5590510.
Multispectral Imaging of Intrinsic Metabolic Fluorophores: Detection of Human Breast Cancer in Fresh Ex Vivo Specimens.
Carver GE, Entwistle MD, Ghule PN, Lee KC, Weaver DL, Sowden MM, Harlow SP, Cintolo-Gonzalez JA, Stein JL, Stein GS
Multispectral Imaging of Intrinsic Metabolic Fluorophores: Detection of Human Breast Cancer in Fresh Ex Vivo Specimens.
Crit Rev Eukaryot Gene Expr
2025;35(3):43-50.doi: 10.1615/CritRevEukaryotGeneExpr.2025057627. PMID: 39964968.
Patient and Caregiver Perceptions of Caregiving Contributions During Cancer Clinical Trials: A Mixed-Methods Study.
Cerutti J, Lent MC, Holcombe RF, Reblin M
Patient and Caregiver Perceptions of Caregiving Contributions During Cancer Clinical Trials: A Mixed-Methods Study.
Cancer Med
2025 Jan;14(1):e70488.doi: 10.1002/cam4.70488. PMID: 39781576; PMCID: PMC11712184.
Real-World Clinical Outcomes in Patients With HER2+ Metastatic Breast Cancer Receiving Tucatinib-Based Therapy After 2 or More Prior Metastatic HER2-Directed Regimens.
Anders C, Neuberger E, Bartley K, Pittner BT, Sow A, Wang S, Kaufman PA
Real-World Clinical Outcomes in Patients With HER2+ Metastatic Breast Cancer Receiving Tucatinib-Based Therapy After 2 or More Prior Metastatic HER2-Directed Regimens.
Cancer Control
Cancer control : journal of the Moffitt Cancer Center. 2025;32() PMID: 40252208; PMCID: PMC7463470.
The social work contribution in end-of-life care.
Fook J, Melekis K
The social work contribution in end-of-life care.
Palliat Care Soc Pract
Palliative care and social practice. 2025;19() PMID: 40678422; PMCID: PMC12267925.